位置:首页 > 蛋白库 > STML2_HUMAN
STML2_HUMAN
ID   STML2_HUMAN             Reviewed;         356 AA.
AC   Q9UJZ1; B4E1K7; D3DRN3; O60376; Q53G29; Q96FY2; Q9P042;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 177.
DE   RecName: Full=Stomatin-like protein 2, mitochondrial;
DE            Short=SLP-2;
DE   AltName: Full=EPB72-like protein 2;
DE   AltName: Full=Paraprotein target 7;
DE            Short=Paratarg-7;
DE   Flags: Precursor;
GN   Name=STOML2; Synonyms=SLP2; ORFNames=HSPC108;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart muscle;
RX   PubMed=10713127; DOI=10.1074/jbc.275.11.8062;
RA   Wang Y., Morrow J.S.;
RT   "Identification and characterization of human SLP-2, a novel homologue of
RT   stomatin (band 7.2b) present in erythrocytes and other tissues.";
RL   J. Biol. Chem. 275:8062-8071(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=11435687; DOI=10.1159/000056902;
RA   Owczarek C.M., Treutlein H.R., Portbury K.J., Gulluyan L.M., Kola I.,
RA   Hertzog P.J.;
RT   "A novel member of the stomatin/EPB72/mec-2 family, stomatin-like 2
RT   (STOML2), is ubiquitously expressed and localizes to HSA chromosome
RT   9p13.1.";
RL   Cytogenet. Cell Genet. 92:196-203(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT PRO-129.
RC   TISSUE=Lung, Pancreas, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-356 (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [9]
RP   PROTEIN SEQUENCE OF 188-197; 201-211 AND 234-250, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (JUN-2005) to UniProtKB.
RN   [10]
RP   PARTIAL PROTEIN SEQUENCE, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16671055; DOI=10.1002/prot.20987;
RA   John J.P., Anrather D., Pollak A., Lubec G.;
RT   "Mass spectrometrical verification of stomatin-like protein 2 (SLP-2)
RT   primary structure.";
RL   Proteins 64:543-551(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-124, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [12]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH MFN2, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17121834; DOI=10.1074/jbc.m608168200;
RA   Hajek P., Chomyn A., Attardi G.;
RT   "Identification of a novel mitochondrial complex containing mitofusin 2 and
RT   stomatin-like protein 2.";
RL   J. Biol. Chem. 282:5670-5681(2007).
RN   [13]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PHB1 AND PHB2.
RX   PubMed=18339324; DOI=10.1016/j.bbamcr.2008.02.006;
RA   Da Cruz S., Parone P.A., Gonzalo P., Bienvenut W.V., Tondera D.,
RA   Jourdain A., Quadroni M., Martinou J.C.;
RT   "SLP-2 interacts with prohibitins in the mitochondrial inner membrane and
RT   contributes to their stability.";
RL   Biochim. Biophys. Acta 1783:904-911(2008).
RN   [14]
RP   FUNCTION IN T-CELL ACTIVATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND INDUCTION.
RX   PubMed=18641330; DOI=10.4049/jimmunol.181.3.1927;
RA   Kirchhof M.G., Chau L.A., Lemke C.D., Vardhana S., Darlington P.J.,
RA   Marquez M.E., Taylor R., Rizkalla K., Blanca I., Dustin M.L., Madrenas J.;
RT   "Modulation of T cell activation by stomatin-like protein 2.";
RL   J. Immunol. 181:1927-1936(2008).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19597348; DOI=10.4161/cbt.8.17.9283;
RA   Wang Y., Cao W., Yu Z., Liu Z.;
RT   "Downregulation of a mitochondria associated protein SLP-2 inhibits tumor
RT   cell motility, proliferation and enhances cell sensitivity to
RT   chemotherapeutic reagents.";
RL   Cancer Biol. Ther. 8:1651-1658(2009).
RN   [16]
RP   IDENTIFICATION AS A COMMON ANTIGEN IN B-CELL NEOPLASMS.
RX   PubMed=19405124; DOI=10.1002/ijc.24427;
RA   Preuss K.D., Pfreundschuh M., Ahlgrimm M., Fadle N., Regitz E.,
RA   Murawski N., Grass S.;
RT   "A frequent target of paraproteins in the sera of patients with multiple
RT   myeloma and MGUS.";
RL   Int. J. Cancer 125:656-661(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-145 AND LYS-233, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   FUNCTION IN CALCIUM HOMEOSTASIS.
RX   PubMed=19944461; DOI=10.1016/j.ceca.2009.10.005;
RA   Da Cruz S., De Marchi U., Frieden M., Parone P.A., Martinou J.C.,
RA   Demaurex N.;
RT   "SLP-2 negatively modulates mitochondrial sodium-calcium exchange.";
RL   Cell Calcium 47:11-18(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION AT SER-17.
RX   PubMed=21791414; DOI=10.1182/blood-2011-04-351668;
RA   Preuss K.D., Pfreundschuh M., Fadle N., Regitz E., Raudies S., Murwaski N.,
RA   Ahlgrimm M., Bittenbring J., Klotz M., Schafer K.H., Held G., Neumann F.,
RA   Grass S.;
RT   "Hyperphosphorylation of autoantigenic targets of paraproteins is due to
RT   inactivation of PP2A.";
RL   Blood 118:3340-3346(2011).
RN   [21]
RP   FUNCTION IN MITOCHONDRIAL BIOGENESIS, SUBCELLULAR LOCATION, INTERACTION
RP   WITH PHB1 AND PHB2, CARDIOLIPIN-BINDING, AND INDUCTION.
RX   PubMed=21746876; DOI=10.1128/mcb.05393-11;
RA   Christie D.A., Lemke C.D., Elias I.M., Chau L.A., Kirchhof M.G., Li B.,
RA   Ball E.H., Dunn S.D., Hatch G.M., Madrenas J.;
RT   "Stomatin-like protein 2 binds cardiolipin and regulates mitochondrial
RT   biogenesis and function.";
RL   Mol. Cell. Biol. 31:3845-3856(2011).
RN   [22]
RP   FUNCTION IN T-CELL ACTIVATION, SUBCELLULAR LOCATION, AND
RP   HOMOOLIGOMERIZATION.
RX   PubMed=22623988; DOI=10.1371/journal.pone.0037144;
RA   Christie D.A., Kirchhof M.G., Vardhana S., Dustin M.L., Madrenas J.;
RT   "Mitochondrial and plasma membrane pools of stomatin-like protein 2
RT   coalesce at the immunological synapse during T cell activation.";
RL   PLoS ONE 7:E37144-E37144(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-327 AND SER-330, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-327 AND SER-330, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Mitochondrial protein that probably regulates the biogenesis
CC       and the activity of mitochondria. Stimulates cardiolipin biosynthesis,
CC       binds cardiolipin-enriched membranes where it recruits and stabilizes
CC       some proteins including prohibitin and may therefore act in the
CC       organization of functional microdomains in mitochondrial membranes.
CC       Through regulation of the mitochondrial function may play a role into
CC       several biological processes including cell migration, cell
CC       proliferation, T-cell activation, calcium homeostasis and cellular
CC       response to stress. May play a role in calcium homeostasis through
CC       negative regulation of calcium efflux from mitochondria. Required for
CC       mitochondrial hyperfusion a pro-survival cellular response to stress
CC       which results in increased ATP production by mitochondria. May also
CC       regulate the organization of functional domains at the plasma membrane
CC       and play a role in T-cell activation through association with the T-
CC       cell receptor signaling complex and its regulation.
CC       {ECO:0000269|PubMed:17121834, ECO:0000269|PubMed:18641330,
CC       ECO:0000269|PubMed:19597348, ECO:0000269|PubMed:19944461,
CC       ECO:0000269|PubMed:21746876, ECO:0000269|PubMed:22623988}.
CC   -!- SUBUNIT: Forms homooligomers. Interacts with MFN2; may form
CC       heterooligomers. Interacts with CACNA2D2 (By similarity). Interacts
CC       with PHB1 and PHB2; recruits them to cardiolipin-enriched mitochondrial
CC       membranes and stabilizes them. {ECO:0000250,
CC       ECO:0000269|PubMed:17121834, ECO:0000269|PubMed:18339324,
CC       ECO:0000269|PubMed:21746876}.
CC   -!- INTERACTION:
CC       Q9UJZ1; Q99700-5: ATXN2; NbExp=3; IntAct=EBI-1044428, EBI-25891409;
CC       Q9UJZ1; O43933: PEX1; NbExp=3; IntAct=EBI-1044428, EBI-988601;
CC       Q9UJZ1; Q9UI14: RABAC1; NbExp=3; IntAct=EBI-1044428, EBI-712367;
CC       Q9UJZ1; O76024: WFS1; NbExp=3; IntAct=EBI-1044428, EBI-720609;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10713127,
CC       ECO:0000269|PubMed:18641330, ECO:0000269|PubMed:21746876,
CC       ECO:0000269|PubMed:22623988}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10713127}. Mitochondrion
CC       {ECO:0000269|PubMed:18641330, ECO:0000269|PubMed:19597348,
CC       ECO:0000269|PubMed:22623988}. Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:17121834, ECO:0000269|PubMed:18339324,
CC       ECO:0000269|PubMed:21746876}; Lipid-anchor
CC       {ECO:0000269|PubMed:21746876}. Mitochondrion intermembrane space
CC       {ECO:0000269|PubMed:17121834}. Membrane raft
CC       {ECO:0000269|PubMed:18641330}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:10713127, ECO:0000269|PubMed:18641330}.
CC       Note=Behaves as an integral membrane protein of the mitochondrion
CC       despite the absence of a detectable transmembrane domain
CC       (PubMed:21746876). Also associates with the actin cytoskeleton and
CC       membrane rafts in activated T-cells (PubMed:18641330, PubMed:10713127).
CC       A minor pool is associated with the plasma membrane and is enriched at
CC       the immunological synapse in activated T-cells (PubMed:22623988).
CC       {ECO:0000269|PubMed:10713127, ECO:0000269|PubMed:18641330,
CC       ECO:0000269|PubMed:21746876, ECO:0000269|PubMed:22623988}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UJZ1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UJZ1-2; Sequence=VSP_054651;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed at low levels. Expressed in
CC       lymphoid tissues (at protein level). {ECO:0000269|PubMed:10713127,
CC       ECO:0000269|PubMed:11435687, ECO:0000269|PubMed:18641330}.
CC   -!- INDUCTION: Up-regulated in activated B- and T-cells and upon
CC       mitochondrial stress by chloramphenicol. {ECO:0000269|PubMed:18641330,
CC       ECO:0000269|PubMed:21746876}.
CC   -!- PTM: Hyperphosphorylated at Ser-17 in some patients with monoclonal
CC       gammopathy of undetermined significance (MGUS), multiple myeloma (MM)
CC       and Waldenstrom macroglobulinemia due to impaired dephosphorylation by
CC       PP2A.
CC   -!- MISCELLANEOUS: Paratarg-7/STOML2 is a frequent autoantigenic target in
CC       monoclonal gammopathy of undetermined significance (MGUS), multiple
CC       myeloma (MM) and Waldenstrom macroglobulinemia, 3 B-cell neoplasms
CC       associated with excessive secretion of a single monoclonal
CC       gammaglobulin (also named paraprotein) in the blood.
CC       {ECO:0000305|PubMed:19405124}.
CC   -!- SIMILARITY: Belongs to the band 7/mec-2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC07983.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAF29073.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/STOML2ID44346ch9p13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF190167; AAF09142.1; -; mRNA.
DR   EMBL; AF282596; AAF91466.1; -; mRNA.
DR   EMBL; AK027405; BAB55091.1; -; mRNA.
DR   EMBL; AK303883; BAG64819.1; -; mRNA.
DR   EMBL; AK223102; BAD96822.1; -; mRNA.
DR   EMBL; AL353795; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004472; AAC07983.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471071; EAW58395.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58396.1; -; Genomic_DNA.
DR   EMBL; BC002442; AAH02442.1; -; mRNA.
DR   EMBL; BC003025; AAH03025.1; -; mRNA.
DR   EMBL; BC010152; AAH10152.1; -; mRNA.
DR   EMBL; BC014990; AAH14990.1; -; mRNA.
DR   EMBL; AF161458; AAF29073.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS6577.1; -. [Q9UJZ1-1]
DR   CCDS; CCDS69588.1; -. [Q9UJZ1-2]
DR   PIR; T02246; T02246.
DR   RefSeq; NP_001273960.1; NM_001287031.1. [Q9UJZ1-2]
DR   RefSeq; NP_001273961.1; NM_001287032.1.
DR   RefSeq; NP_038470.1; NM_013442.2. [Q9UJZ1-1]
DR   AlphaFoldDB; Q9UJZ1; -.
DR   SMR; Q9UJZ1; -.
DR   BioGRID; 119062; 241.
DR   IntAct; Q9UJZ1; 80.
DR   MINT; Q9UJZ1; -.
DR   STRING; 9606.ENSP00000348886; -.
DR   GlyGen; Q9UJZ1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UJZ1; -.
DR   MetOSite; Q9UJZ1; -.
DR   PhosphoSitePlus; Q9UJZ1; -.
DR   SwissPalm; Q9UJZ1; -.
DR   BioMuta; STOML2; -.
DR   DMDM; 60415944; -.
DR   OGP; Q9UJZ1; -.
DR   REPRODUCTION-2DPAGE; IPI00334190; -.
DR   CPTAC; CPTAC-595; -.
DR   CPTAC; CPTAC-596; -.
DR   EPD; Q9UJZ1; -.
DR   jPOST; Q9UJZ1; -.
DR   MassIVE; Q9UJZ1; -.
DR   MaxQB; Q9UJZ1; -.
DR   PaxDb; Q9UJZ1; -.
DR   PeptideAtlas; Q9UJZ1; -.
DR   PRIDE; Q9UJZ1; -.
DR   ProteomicsDB; 5767; -.
DR   ProteomicsDB; 84697; -. [Q9UJZ1-1]
DR   TopDownProteomics; Q9UJZ1-1; -. [Q9UJZ1-1]
DR   Antibodypedia; 25758; 277 antibodies from 29 providers.
DR   DNASU; 30968; -.
DR   Ensembl; ENST00000356493.10; ENSP00000348886.5; ENSG00000165283.16. [Q9UJZ1-1]
DR   Ensembl; ENST00000452248.6; ENSP00000395743.2; ENSG00000165283.16. [Q9UJZ1-2]
DR   GeneID; 30968; -.
DR   KEGG; hsa:30968; -.
DR   MANE-Select; ENST00000356493.10; ENSP00000348886.5; NM_013442.3; NP_038470.1.
DR   UCSC; uc003zwi.5; human. [Q9UJZ1-1]
DR   CTD; 30968; -.
DR   DisGeNET; 30968; -.
DR   GeneCards; STOML2; -.
DR   HGNC; HGNC:14559; STOML2.
DR   HPA; ENSG00000165283; Low tissue specificity.
DR   MIM; 608292; gene.
DR   neXtProt; NX_Q9UJZ1; -.
DR   OpenTargets; ENSG00000165283; -.
DR   PharmGKB; PA37897; -.
DR   VEuPathDB; HostDB:ENSG00000165283; -.
DR   eggNOG; KOG2620; Eukaryota.
DR   GeneTree; ENSGT01030000234614; -.
DR   InParanoid; Q9UJZ1; -.
DR   OMA; TQIRAEM; -.
DR   OrthoDB; 1237942at2759; -.
DR   PhylomeDB; Q9UJZ1; -.
DR   TreeFam; TF105750; -.
DR   PathwayCommons; Q9UJZ1; -.
DR   Reactome; R-HSA-8949664; Processing of SMDT1.
DR   SignaLink; Q9UJZ1; -.
DR   SIGNOR; Q9UJZ1; -.
DR   BioGRID-ORCS; 30968; 47 hits in 1092 CRISPR screens.
DR   ChiTaRS; STOML2; human.
DR   GeneWiki; STOML2; -.
DR   GenomeRNAi; 30968; -.
DR   Pharos; Q9UJZ1; Tbio.
DR   PRO; PR:Q9UJZ1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q9UJZ1; protein.
DR   Bgee; ENSG00000165283; Expressed in apex of heart and 201 other tissues.
DR   ExpressionAtlas; Q9UJZ1; baseline and differential.
DR   Genevisible; Q9UJZ1; HS.
DR   GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:1901612; F:cardiolipin binding; IDA:UniProtKB.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc.
DR   GO; GO:0035710; P:CD4-positive, alpha-beta T cell activation; ISS:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0010876; P:lipid localization; ISS:UniProtKB.
DR   GO; GO:0006851; P:mitochondrial calcium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0034982; P:mitochondrial protein processing; ISS:UniProtKB.
DR   GO; GO:0007005; P:mitochondrion organization; IMP:UniProtKB.
DR   GO; GO:1900210; P:positive regulation of cardiolipin metabolic process; IMP:UniProtKB.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; ISS:UniProtKB.
DR   GO; GO:0090297; P:positive regulation of mitochondrial DNA replication; IMP:UniProtKB.
DR   GO; GO:0010918; P:positive regulation of mitochondrial membrane potential; IMP:UniProtKB.
DR   GO; GO:0051259; P:protein complex oligomerization; IDA:UniProtKB.
DR   GO; GO:0042776; P:proton motive force-driven mitochondrial ATP synthesis; IMP:UniProtKB.
DR   GO; GO:1990046; P:stress-induced mitochondrial fusion; ISS:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IMP:UniProtKB.
DR   Gene3D; 3.30.479.30; -; 1.
DR   InterPro; IPR001107; Band_7.
DR   InterPro; IPR036013; Band_7/SPFH_dom_sf.
DR   InterPro; IPR032435; Band_7_C.
DR   InterPro; IPR001972; Stomatin_HflK_HflKC_fam.
DR   Pfam; PF01145; Band_7; 1.
DR   Pfam; PF16200; Band_7_C; 1.
DR   PRINTS; PR00721; STOMATIN.
DR   SMART; SM00244; PHB; 1.
DR   SUPFAM; SSF117892; SSF117892; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Lipid-binding; Lipoprotein;
KW   Membrane; Mitochondrion; Mitochondrion inner membrane; Phosphoprotein;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..28
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000305"
FT   CHAIN           29..356
FT                   /note="Stomatin-like protein 2, mitochondrial"
FT                   /id="PRO_0000094031"
FT   REGION          321..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          215..252
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        326..341
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        342..356
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         17
FT                   /note="Phosphoserine; by PKC/PRKCZ"
FT                   /evidence="ECO:0000269|PubMed:21791414"
FT   MOD_RES         124
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15592455"
FT   MOD_RES         145
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         145
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JB2"
FT   MOD_RES         233
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         327
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         149..193
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054651"
FT   VARIANT         129
FT                   /note="L -> P (in dbSNP:rs17856326)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_026830"
FT   CONFLICT        14
FT                   /note="L -> M (in Ref. 5; AAC07983)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        83
FT                   /note="V -> I (in Ref. 4; BAD96822)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        202
FT                   /note="A -> P (in Ref. 8; AAF29073)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   356 AA;  38534 MW;  672331B57C82654E CRC64;
     MLARAARGTG ALLLRGSLLA SGRAPRRASS GLPRNTVVLF VPQQEAWVVE RMGRFHRILE
     PGLNILIPVL DRIRYVQSLK EIVINVPEQS AVTLDNVTLQ IDGVLYLRIM DPYKASYGVE
     DPEYAVTQLA QTTMRSELGK LSLDKVFRER ESLNASIVDA INQAADCWGI RCLRYEIKDI
     HVPPRVKESM QMQVEAERRK RATVLESEGT RESAINVAEG KKQAQILASE AEKAEQINQA
     AGEASAVLAK AKAKAEAIRI LAAALTQHNG DAAASLTVAE QYVSAFSKLA KDSNTILLPS
     NPGDVTSMVA QAMGVYGALT KAPVPGTPDS LSSGSSRDVQ GTDASLDEEL DRVKMS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025